Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
147.1 USD | +0.63% | +1.14% | +24.49% |
May. 27 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection | MT |
May. 15 | UBS Raises Crane's Price Target to $152 From $120, Maintains Neutral Rating | MT |
- Stock Market
- Equities
- CR Stock
- News Crane Company
- Analyst Reco.